2010-04-28 – China Stock Advice

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXING CAPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used in connection with several pharmaceutical products sold in the province are not within approved parameters. Biostar Pharmaceuticals’ flagship Hepatitis B]

By info| 2016-03-03T14:33:54+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-04-28, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES NEW ADVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXING CAPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used in connection with several pharmaceutical products sold in the province are not within approved parameters. Biostar Pharmaceuticals’ flagship Hepatitis B]

By info| 2016-03-03T14:36:01+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2010-04-28, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: (Original Filing)

[News Release Contact: Siliconware Precision Industries Co., Ltd. No.45, Jieh Show Rd. Hsinchu Science Park, Hsinchu Taiwan, 30056 www.spil.com.tw Janet Chen, IR Director janet@spil.com.tw +886-3-5795678#3675 Byron Chiang, Spokesperson byronc@spil.com.tw +886-3-5795678#3671 Siliconware Precision Industries Reports a 10.5% Quarter-over-Quarter Decline in Revenues Resulting in Earnings per Share of NT$ 0.48 or Earnings per ADS of US$ 0.08 for First Quarter 2010 Siliconware]

By info| 2016-03-31T10:58:01+00:00 April 28th, 2010|Categories: Chinese Stocks, SEC Original, SPIL|Tags: 0001111759, 2010-04-28, 3674, 6-K, SEMICONDUCTORS and RELATED DEVICES, SPIL|0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: News Release Contact: Siliconware Precision Industries Co., Ltd.

[News Release Contact: Siliconware Precision Industries Co., Ltd. No.45, Jieh Show Rd. Hsinchu Science Park, Hsinchu Taiwan, 30056 www.spil.com.tw Janet Chen, IR Director janet@spil.com.tw +886-3-5795678#3675 Byron Chiang, Spokesperson byronc@spil.com.tw +886-3-5795678#3671 Siliconware Precision Industries Reports a 10.5% Quarter-over-Quarter Decline in Revenues Resulting in Earnings per Share of NT$ 0.48 or Earnings per ADS of US$ 0.08 for First Quarter 2010 Siliconware]

By info| 2016-03-31T10:59:00+00:00 April 28th, 2010|Categories: Chinese Stocks, SPIL, Webplus ver|Tags: 0001111759, 2010-04-28, 3674, 6-K, SEMICONDUCTORS and RELATED DEVICES, SPIL|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By info| 2016-02-07T17:30:24+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2010-04-28, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By info| 2016-02-07T17:31:04+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2010-04-28, 2834, 8-K, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Announces Closing of Public Offering of Common Stock HANGZHOU, China--(BUSINESS WIRE)--April 28, 2010--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJDD) ("Jo-Jo Drugstores" or the "Company"), which operates a retail pharmacy chain in the People’s Republic of China (the “PRC”), today announced that it closed its previously announced public offering of 3.5 million shares of common stock. Gross proceeds to]

By info| 2016-03-11T07:33:39+00:00 April 28th, 2010|Categories: Chinese Stocks, CJJD, SEC Original|Tags: 0001413263, 2010-04-28, 2833, 8-K, CJJD, MEDICINAL CHEMICALS and BOTANICAL PRODUCTS|0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores, Inc. Announces Closing of Public

[China Jo-Jo Drugstores, Inc. Announces Closing of Public Offering of Common Stock HANGZHOU, China--(BUSINESS WIRE)--April 28, 2010--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJDD) ("Jo-Jo Drugstores" or the "Company"), which operates a retail pharmacy chain in the People’s Republic of China (the “PRC”), today announced that it closed its previously announced public offering of 3.5 million shares of common stock. Gross proceeds to]

By info| 2016-03-11T07:34:29+00:00 April 28th, 2010|Categories: Chinese Stocks, CJJD, Webplus ver|Tags: 0001413263, 2010-04-28, 2833, 8-K, CJJD, MEDICINAL CHEMICALS and BOTANICAL PRODUCTS|0 Comments

CCM [Concord Medical Services] 6-K: (Original Filing)

[Concord Medical Enters Agreement to Acquire Four Radiotherapy and Diagnostic Imaging Acquisition to Strengthen Companys Presence in Northern China BEIJING, CHINA, April 27, 2010 Concord Medical Services Holdings Limited (Concord Medical or the Company) (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its wholly-owned subsidiary, Shenzhen Aohua Medical Device] [FORM 6-K CONCORD MEDICAL SERVICES 18/F, Tower A, Global Trade Center þ o Form 20-F o o o þ Yes N/A 82- TABLE OF CONTENTS TABLE OF CONTENTS Press release regarding the acquisition of four radiotherapy and diagnostic imaging centers in Hebei province 2 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President 3 6-K]

By info| 2016-03-13T12:11:24+00:00 April 28th, 2010|Categories: CCM, Chinese Stocks, SEC Original|Tags: 0001472072, 2010-04-28, 6-K, 8011, CCM, SERVICES-OFFICES and CLINICS OF DOCTORS OF MEDICINE|0 Comments

CCM [Concord Medical Services] 6-K: Concord Medical Enters Agreement to Acquire Four Radiotherapy

[Concord Medical Enters Agreement to Acquire Four Radiotherapy and Diagnostic Imaging Acquisition to Strengthen Companys Presence in Northern China BEIJING, CHINA, April 27, 2010 Concord Medical Services Holdings Limited (Concord Medical or the Company) (NYSE: CCM), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its wholly-owned subsidiary, Shenzhen Aohua Medical Device] [FORM 6-K CONCORD MEDICAL SERVICES 18/F, Tower A, Global Trade Center þ o Form 20-F o o o þ Yes N/A 82- TABLE OF CONTENTS TABLE OF CONTENTS Press release regarding the acquisition of four radiotherapy and diagnostic imaging centers in Hebei province 2 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Jianyu Yang Director, Chief Executive Officer and President 3 6-K]

By info| 2016-03-13T12:12:44+00:00 April 28th, 2010|Categories: CCM, Chinese Stocks, Webplus ver|Tags: 0001472072, 2010-04-28, 6-K, 8011, CCM, SERVICES-OFFICES and CLINICS OF DOCTORS OF MEDICINE|0 Comments